Pirtobrutinib,Ibrutinib,Acalabrutinib,Zanubrutinib
eli lilly,astrazeneca,beigene
['bruin mcl-321', 'lymphoma', 'mantle,(-dismantle)', 'lymsm', 'bruin', 'bruin,mcl,321', 'valent ,(-prevalent),(-equivalent),(-bivalent)', 'valent ,(-prevalent)', 'loxo']
bruin mcl-321: a phase 3, open-label, randomized study of a non-covalent (reversible) btki versus investigator's choice of btki in patients w/ previously treated, btki na ve #mantlecelllymphoma. #lymsm trial in progress poster at #asco23: 
Dedicated to communicating the latest science & innovation from Loxo@Lilly. Tweets intended for US oncology HCPs. See our community guidelines: https://t.co/1q8vAe63mK